[No standalone website (unbranded, no questionnaire)] A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site

Study’s contact

Call center

650-622-7508

Email address

Jeannie.hou@rakuten-med.com

Condition

Head and Neck Cancer

Treatment type

Interventional

Investigational product

ASP-1929

Phase

Phase 3

Sponsor

Rakuten Medical, Inc.

ClinicalTrials.gov identifier

NCT03769506

Study number

ASP-1929-301

Understanding clinical trials

Get answers to your questions about clinical trials.

About the study

This study will evaluate the efficacy and safety of ASP-1929 Photoimmunotherapy as a monotherapy for the treatment of locoregional, recurrent head and neck squamous cell carcinoma in patients who have failed or progressed on or after at least two lines of therapy.

Who can take part?

You may be eligible to participate in the study if you meet the following criteria:

For a full list of inclusion/exclusion criteria, please visit ClinicalTrials.gov

Study locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site